Immune thrombocytopenia (ITP): vizsgálatok itt: Litvánia

1 trial · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.

• 2/3. fázisTaking people
  A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)

  Where

  Kaunas, Vilnius

  Életkor

  12 év to 17 év

  People

  24 worldwide

  Run by

  argenx

  See details and how to joinNCT07194850 · EU 2025-521055-23-00